161 related articles for article (PubMed ID: 33835138)
21. Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.
Yang T; Zhang J; Lu JH; Yang GS; Wu MC; Yu WF
World J Surg; 2011 Sep; 35(9):2073-82. PubMed ID: 21656309
[TBL] [Abstract][Full Text] [Related]
22. Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology.
Jung DH; Hwang S; Lee YJ; Kim KH; Song GW; Ahn CS; Moon DB; Lee SG
Ann Surg; 2019 Mar; 269(3):511-519. PubMed ID: 28837444
[TBL] [Abstract][Full Text] [Related]
23. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
24. Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma.
Qiao G; Li J; Huang A; Yan Z; Lau WY; Shen F
J Gastroenterol Hepatol; 2014 Dec; 29(12):2014-20. PubMed ID: 24989634
[TBL] [Abstract][Full Text] [Related]
25. Comparison of RETREAT and CCFSS Scoring Systems for Risk Estimation of Hepatocellular Carcinoma Recurrence After Radical Resection.
Zhang S; Zhang X; Mo C; Luo Y
Altern Ther Health Med; 2023 Nov; 29(8):694-698. PubMed ID: 37678878
[TBL] [Abstract][Full Text] [Related]
26. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation.
Harada N; Shirabe K; Ikeda Y; Korenaga D; Takenaka K; Maehara Y
Ann Transplant; 2012 Dec; 17(4):11-20. PubMed ID: 23274319
[TBL] [Abstract][Full Text] [Related]
28. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
[TBL] [Abstract][Full Text] [Related]
29. Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence.
Huo TI; Lui WY; Wu JC; Huang YH; King KL; Loong CC; Lee PC; Chang FY; Lee SD
World J Surg; 2004 Mar; 28(3):258-62. PubMed ID: 14961198
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
31. Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital.
Yeh CN; Lee WC; Chen MF
Ann Surg Oncol; 2003 Nov; 10(9):1070-6. PubMed ID: 14597446
[TBL] [Abstract][Full Text] [Related]
32. New scoring system for resectable hepatocellular carcinoma with a maximum tumor size of ≤5 cm based on preoperative tumor factors.
Kawasaki Y; Yang SJ; Choi GH; Han DH; Lee JH; Iino S; Sakoda M; Ueno S; Natsugoe S; Choi JS
HPB (Oxford); 2019 Oct; 21(10):1393-1399. PubMed ID: 30922846
[TBL] [Abstract][Full Text] [Related]
33. Prognostic model for identifying candidates for hepatectomy among patients with hepatocellular carcinoma and hepatic vein invasion.
Zhang XP; Wang K; Gao YZ; Wei XB; Lu CD; Chai ZT; Zhen ZJ; Li J; Yang DH; Zhou D; Fan RF; Yan ML; Xia YJ; Liu B; Huang YQ; Zhang F; Hu YR; Zhong CQ; Lin JH; Fang KP; Cheng ZH; Wu MC; Lau WY; Cheng SQ;
Br J Surg; 2020 Jun; 107(7):865-877. PubMed ID: 32246475
[TBL] [Abstract][Full Text] [Related]
34. Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making.
Zhang YF; Zhou J; Wei W; Zou RH; Chen MS; Lau WY; Shi M; Guo RP
Br J Cancer; 2016 Oct; 115(9):1039-1047. PubMed ID: 27701389
[TBL] [Abstract][Full Text] [Related]
35. RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.
Hsu HY; Yu MC; Lee CW; Tsai HI; Sung CM; Chen CW; Huang SW; Lin CY; Jeng WJ; Lee WC; Chen MF
BMC Cancer; 2017 Nov; 17(1):742. PubMed ID: 29121890
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.
Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Kakisaka T; Tsuruga Y; Todo S; Taketomi A
World J Surg Oncol; 2012 Jun; 10():107. PubMed ID: 22697061
[TBL] [Abstract][Full Text] [Related]
37. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.
Cai BB; Shi KQ; Li P; Chen BC; Shi L; Johnson PJ; Lai P; Toyoda H; Zhou MT
Clin Chim Acta; 2018 Oct; 485():187-194. PubMed ID: 29908940
[TBL] [Abstract][Full Text] [Related]
38. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
39. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
40. Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection.
Chen S; Wang C; Cui A; Yu K; Huang C; Zhu M; Chen M
Cell Physiol Biochem; 2018; 48(2):491-502. PubMed ID: 30016793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
